We are live on ! Find out more
KRRO icon

Korro Bio

43 hedge funds and large institutions have $2.52M invested in Korro Bio in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

6.63% less ownership

Funds ownership: 20.84% → 14.21% (-6.6%)

10% less funds holding

Funds holding: 48 → 43 (-5)

29% less call options, than puts

Call options by funds: $37K | Put options by funds: $52K

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

89% less capital inflows, than outflows

Capital inflows: $1.18M | Capital outflows: $10.4M

Holders
43
Holders Change
-5
Holders Change %
-10.42%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
7
Closed
12
Calls
$37K
Puts
$52K
Net Calls
-$15K
Net Calls Change
-$242K

KRRO Hedge Fund Activity: Q1 2023 in Review

43 of the 6,290 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q1 2023, worth a combined $2.52M — down 91% from $28.1M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of KRRO and 7 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 11 added.

The largest buyer was Acadian Asset Management, opening a new position worth an estimated $321K. The largest seller was Federated Hermes, exiting entirely with an estimated $5.05M sold.

  • 43 institutional investors held Korro Bio (KRRO) as of Q1 2023, down from 48 in Q4 2022.
  • Funds reported $2.52M of Korro Bio stock for Q1 2023, down 91% quarter-over-quarter.
  • 7 funds opened new Korro Bio positions in Q1 2023 and 12 closed out, a net change of -5 holders.
  • The largest Korro Bio buyer in Q1 2023 was Acadian Asset Management, an estimated $321K added.
  • The largest Korro Bio seller in Q1 2023 was Federated Hermes, an estimated $5.05M sold.

Based on aggregated 13F filings for Q1 2023.